First case of insulin neuritis after islet transplantation

Meillet, L.; Penfornis, A.; Benhamou, Pierre‐Yves; Berney, Thierry; Borot, S.

doi:10.1007/s00592-018-01280-8

Cited by 2 publications

(5 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…13 Its prevalence in subjects with diabetes in a third-level reference centre was reported to be 10.9%. 13 Cases reported in the literature 4,[14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31] show that the mean age of those affected by TIND is 36.55 years (95% , and that there is a slight male predominance (57.14% vs 42.86%). Type 1 DM was more frequent than type 2 DM (64.29% vs 35.71%), and patients had the disease for a mean of 4.9 years (95% CI 3.17-6.64).…”

Section: Epidemiologymentioning

confidence: 99%

“…Case reports of treatment-induced neuropathy of diabetes. 4,[14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31] (Continued on from the previous 2 pages)…”

Section: Key Pointsmentioning

confidence: 99%

“…Cases reported in the literature 4,14–31 show that the mean age of those affected by TIND is 36.55 years (95% CI 30.99–42.11), and that there is a slight male predominance (57.14% vs 42.86%). Type 1 DM was more frequent than type 2 DM (64.29% vs 35.71%), and patients had the disease for a mean of 4.9 years (95% CI 3.17–6.64).…”

Section: Epidemiologymentioning

confidence: 99%

“…Treatment of TIND includes the use of the same drugs prescribed for painful diabetic neuropathy and the maintenance of adequate glycaemic control Case reports of treatment-induced neuropathy of diabetes 4,[14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31]. (Continued on the next 2 pages)…”

mentioning

confidence: 99%

“…4,[14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31] (Continued on the next page)…”

mentioning

confidence: 99%

See 4 more Smart Citations

Treatment‐induced neuropathy of diabetes: an update

Quiroz‐Aldave,

Concepción‐Zavaleta,

del Carmen Durand‐Vásquez

et al. 2023

Practical Diabetes

View full text Add to dashboard Cite

Background and aims: Treatment‐induced neuropathy of diabetes is an acute small‐fibre neuropathy associated with rapid glycaemia improvement.Methods: This study is a narrative review carried out based on a bibliographic review, using articles indexed in PubMed/Medline and Scielo.Results: This entity is more frequent in adult patients with poor previous glycaemic control. Its precise pathophysiology is unknown, but it is likely related to unrestored microcirculation changes that occurred during the hyperglycaemic period. It presents with intense, sudden neuropathic pain and autonomic dysfunction after a rapid glycaemic correction and a poorer analgesic response than in diabetic neuropathy.Conclusions: Since rapid glycaemia correction is the cause of this problem, clinical practice guidelines that can help physicians to prevent, diagnose and manage this entity should be developed. Copyright © 2023 John Wiley & Sons.

show abstract

Section: Epidemiologymentioning

confidence: 99%

“…Case reports of treatment-induced neuropathy of diabetes. 4,[14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31] (Continued on from the previous 2 pages)…”

Section: Key Pointsmentioning

confidence: 99%

Section: Epidemiologymentioning

confidence: 99%

mentioning

confidence: 99%

“…4,[14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31] (Continued on the next page)…”

mentioning

confidence: 99%

See 3 more Smart Citations

Treatment‐induced neuropathy of diabetes: an update

Quiroz‐Aldave,

Concepción‐Zavaleta,

del Carmen Durand‐Vásquez

et al. 2023

Practical Diabetes

View full text Add to dashboard Cite

show abstract

Diabetes, Diabetic Complications, and Phosphate Toxicity: A Scoping Review

Brown

2020

CDR

View full text Add to dashboard Cite

: This article presents a scoping review and synthesis of research findings investigating the toxic cellular accumulation of dysregulated inorganic phosphate—phosphate toxicity—as a pathophysiological determinant of diabetes and diabetic complications. Phosphorus, an essential micronutrient, is closely linked to the cellular metabolism of glucose for energy production, and serum inorganic phosphate is often transported into cells along with glucose during insulin therapy. Mitochondrial dysfunction and apoptosis, endoplasmic reticulum stress, neuronal degeneration, and pancreatic cancer are associated with dysregulated levels of phosphate in diabetes. Ectopic calcification involving deposition of calcium-phosphate crystals is prevalent throughout diabetic complications including vascular calcification, nephropathy, retinopathy, and bone disorders. A low-glycemic, low-phosphate dietary intervention is proposed for further investigations in the treatment and prevention of diabetes and related diabetic pathologies.

show abstract

First case of insulin neuritis after islet transplantation

Cited by 2 publications

References 5 publications

Treatment‐induced neuropathy of diabetes: an update

Treatment‐induced neuropathy of diabetes: an update

Diabetes, Diabetic Complications, and Phosphate Toxicity: A Scoping Review

Contact Info

Product

Resources

About